Recommended

Register now: Enhancing biopharma workflows with the power of UV/Vis spectroscopy webinar
Download our brand new eBook: A practical guide to single-use filtration in biopharma.
Join us as we look at how the outsourcing of buffers is helping biopharma drug manufacturers to streamline their processes.
Discover more on how Polpharma API meets evolving regulatory guidance around N-nitrosamines control in APIs with Waters’ high-performance analysis instruments.
Learn more about leveraging real-world data, the practical applications of AI and adopting configurable LC/NC solutions.
Download this compendium to discover how hot-melt extrusion can help to overcome pharmaceutical formulation challenges
whitepaper

Whitepaper: PAT leads the way in the adoption of continuous manufacturing processes

Martin Gadsby, CEO & Director at Optimal Industrial Technologies and Flavio Belvedere, Co-Founder of ABCS Srl, look at the benefits of PAT and the aspects to consider when deploying it.

The use of data to gain actionable insight into manufacturing and processing activities, to optimise them and attain continuous flows, is at the heart of the fourth industrial revolution. In the chemical and biotechnology sectors, where complex chemical reactions and bioprocesses may be required to deliver key products, it is essential to have an in-depth, data-driven understanding of how critical process parameters (CPPs) influence a product’s critical quality attributes (CQAs). To achieve this, businesses should implement process analytical technology (PAT) strategies. In this way, they can manage the complexity of, and effectively control, their processes. This article describes the benefits of this approach and what should be considered when deploying PAT for continuous processing and manufacturing.